BARCLAYS PLC - TALARIS THERAPEUTICS INC ownership

TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 54 filers reported holding TALARIS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of TALARIS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$50
+138.1%
17,696
+151.0%
0.00%
Q2 2023$21
-40.0%
7,049
-62.4%
0.00%
Q1 2023$35
+169.2%
18,760
+41.7%
0.00%
Q4 2022$13
-99.9%
13,242
+65.0%
0.00%
Q3 2022$22,000
-40.5%
8,027
-1.8%
0.00%
Q2 2022$37,000
-67.5%
8,174
-29.4%
0.00%
Q1 2022$114,00011,5800.00%
Other shareholders
TALARIS THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Qiming U.S. Ventures Management, LLC 2,932,606$7,713,00011.20%
Aisling Capital Management LP 175,000$460,0000.30%
Artal Group S.A. 2,064,262$5,429,0000.23%
Cormorant Asset Management, LP 900,649$2,369,0000.17%
Eventide Asset Management 1,561,092$4,106,0000.08%
Blackstone Inc. 8,089,315$21,2750.08%
Logos Global Management LP 197,913$521,0000.06%
Values First Advisors, Inc. 30,715$81,0000.06%
VIKING GLOBAL INVESTORS LP 3,289,617$8,652,0000.04%
CAAS CAPITAL MANAGEMENT LP 297,707$783,0000.04%
View complete list of TALARIS THERAPEUTICS INC shareholders